BAMCO Inc
MRVI icon

BAMCO Inc’s Maravai LifeSciences MRVI Stock Holding History

BAMCO Inc’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,203,651
Closed -$12M – 330
2024
Q4 		$12M Buy
2,203,651
+80,000
+4% +$515K 0.03% 225
2024
Q3 		$17.6M Hold
2,123,651
– – 0.05% 213
2024
Q2 		$15.2M Hold
2,123,651
– – 0.04% 222
2024
Q1 		$18.4M Buy
2,123,651
+640,000
+43% +$4.33M 0.05% 215
2023
Q4 		$9.72M Buy
1,483,651
+802,482
+118% +$5.18M 0.03% 235
2023
Q3 		$6.81M Hold
681,169
– – 0.02% 245
2023
Q2 		$8.47M Buy
681,169
+32,169
+5% +$434K 0.02% 240
2023
Q1 		$9.09M Buy
649,000
+133,000
+26% +$1.91M 0.03% 233
2022
Q4 		$7.38M Buy
+516,000
New +$8.12M 0.02% 243

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.05B AUM 22.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc's MRVI Position: Q1 2025 in Review

BAMCO Inc sold out of Maravai LifeSciences (MRVI) in Q1 2025, closing a stake of 2,203,651 shares — an estimated $12M sold.

BAMCO Inc first reported a position in MRVI in Q4 2022 and held it in 9 quarters. The position peaked at $18.4M in Q1 2024. 184 funds tracked by Wall St. Rank hold MRVI as of Q1 2025.

  • BAMCO Inc reported no remaining Maravai LifeSciences position as of Q1 2025 after selling out during the quarter.
  • BAMCO Inc sold 2,203,651 Maravai LifeSciences shares in Q1 2025, an estimated $12M.
  • BAMCO Inc first reported a position in Maravai LifeSciences in Q4 2022 and held it in 9 quarters.
  • BAMCO Inc's Maravai LifeSciences position peaked at $18.4M in Q1 2024.
  • 184 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2025.

Based on BAMCO Inc's 13F filing for Q1 2025, filed 15 May 2025.